These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 9525742)
1. A transforming p53 mutant, which binds DNA, transactivates and induces apoptosis reveals a nuclear:cytoplasmic shuttling defect. Crook T; Parker GA; Rozycka M; Crossland S; Allday MJ Oncogene; 1998 Mar; 16(11):1429-41. PubMed ID: 9525742 [TBL] [Abstract][Full Text] [Related]
2. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression. Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270 [TBL] [Abstract][Full Text] [Related]
4. Regulation of DNA binding and transactivation in p53 by nuclear localization and phosphorylation. Martinez JD; Craven MT; Joseloff E; Milczarek G; Bowden GT Oncogene; 1997 May; 14(21):2511-20. PubMed ID: 9191051 [TBL] [Abstract][Full Text] [Related]
5. Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion. Knippschild U; Oren M; Deppert W Oncogene; 1996 Apr; 12(8):1755-65. PubMed ID: 8622896 [TBL] [Abstract][Full Text] [Related]
6. Increased apoptosis induction by 121F mutant p53. Saller E; Tom E; Brunori M; Otter M; Estreicher A; Mack DH; Iggo R EMBO J; 1999 Aug; 18(16):4424-37. PubMed ID: 10449408 [TBL] [Abstract][Full Text] [Related]
7. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53. Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938 [TBL] [Abstract][Full Text] [Related]
9. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1. Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602 [TBL] [Abstract][Full Text] [Related]
10. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements. Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705 [TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax. Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521 [TBL] [Abstract][Full Text] [Related]
12. Nuclear exclusion of p53 in a subset of tumors requires MDM2 function. Lu W; Pochampally R; Chen L; Traidej M; Wang Y; Chen J Oncogene; 2000 Jan; 19(2):232-40. PubMed ID: 10645001 [TBL] [Abstract][Full Text] [Related]
13. Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression. Kallassy M; Martel N; Damour O; Yamasaki H; Nakazawa H Mol Carcinog; 1998 Jan; 21(1):26-36. PubMed ID: 9473769 [TBL] [Abstract][Full Text] [Related]
14. A novel p53 mutant retained functional activity in lung carcinomas. Ko JL; Chiao MC; Chang SL; Lin P; Lin JC; Sheu GT; Lee H DNA Repair (Amst); 2002 Sep; 1(9):755-62. PubMed ID: 12509279 [TBL] [Abstract][Full Text] [Related]
15. [Nuclear import of p53 in relation to MDM2-mediated degradation and ubiquitination]. Li HP; Zhang YP Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):86-9. PubMed ID: 15946545 [TBL] [Abstract][Full Text] [Related]
16. Induction of Mdm2 and enhancement of cell survival by bFGF. Shaulian E; Resnitzky D; Shifman O; Blandino G; Amsterdam A; Yayon A; Oren M Oncogene; 1997 Nov; 15(22):2717-25. PubMed ID: 9400998 [TBL] [Abstract][Full Text] [Related]
17. Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells. David-Pfeuty T; Chakrani F; Ory K; Nouvian-Dooghe Y Cell Growth Differ; 1996 Sep; 7(9):1211-25. PubMed ID: 8877102 [TBL] [Abstract][Full Text] [Related]
18. ZBP-89 promotes growth arrest through stabilization of p53. Bai L; Merchant JL Mol Cell Biol; 2001 Jul; 21(14):4670-83. PubMed ID: 11416144 [TBL] [Abstract][Full Text] [Related]
19. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation. Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840 [TBL] [Abstract][Full Text] [Related]
20. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain. Roth J; Koch P; Contente A; Dobbelstein M Oncogene; 2000 Mar; 19(14):1834-42. PubMed ID: 10777217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]